104 related articles for article (PubMed ID: 8386506)
1. The thyroid hormone receptor interferes with transcriptional activation via the AP-1 complex.
Schmidt ED; Cramer SJ; Offringa R
Biochem Biophys Res Commun; 1993 Apr; 192(1):151-60. PubMed ID: 8386506
[TBL] [Abstract][Full Text] [Related]
2. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
Sharif M; Privalsky ML
Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
[TBL] [Abstract][Full Text] [Related]
3. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
4. An activator protein-1 (AP-1) response element on pro alpha1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts.
Lee HW; Klein LE; Raser J; Eghbali-Webb M
J Mol Cell Cardiol; 1998 Nov; 30(11):2495-506. PubMed ID: 9925384
[TBL] [Abstract][Full Text] [Related]
5. A c-erb-A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone.
Glass CK; Franco R; Weinberger C; Albert VR; Evans RM; Rosenfeld MG
Nature; 1987 Oct 22-28; 329(6141):738-41. PubMed ID: 3313046
[TBL] [Abstract][Full Text] [Related]
6. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing.
Koenig RJ; Lazar MA; Hodin RA; Brent GA; Larsen PR; Chin WW; Moore DD
Nature; 1989 Feb; 337(6208):659-61. PubMed ID: 2537467
[TBL] [Abstract][Full Text] [Related]
8. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
9. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
[TBL] [Abstract][Full Text] [Related]
10. Negative transcriptional regulation by nuclear receptors.
Saatcioglu F; Claret FX; Karin M
Semin Cancer Biol; 1994 Oct; 5(5):347-59. PubMed ID: 7849263
[TBL] [Abstract][Full Text] [Related]
11. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
13. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
Bhat MK; McPhie P; Cheng S
Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
[TBL] [Abstract][Full Text] [Related]
14. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
[TBL] [Abstract][Full Text] [Related]
15. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
16. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
Claret FX; Hibi M; Dhut S; Toda T; Karin M
Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781
[TBL] [Abstract][Full Text] [Related]
17. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex.
Kim H; Lee JE; Cho EJ; Liu JO; Youn HD
Cancer Res; 2003 Oct; 63(19):6135-9. PubMed ID: 14559791
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells.
Niederman TM; Hastings WR; Luria S; Bandres JC; Ratner L
Virology; 1993 May; 194(1):338-44. PubMed ID: 8480425
[TBL] [Abstract][Full Text] [Related]
20. The c-erb-A protein is a high-affinity receptor for thyroid hormone.
Sap J; Muñoz A; Damm K; Goldberg Y; Ghysdael J; Leutz A; Beug H; Vennström B
Nature; 1986 Dec 18-31; 324(6098):635-40. PubMed ID: 2879242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]